More articles about: Radiation Oncology

Linda Rossi was initially diagnosed with lung cancer and moved to Michigan for treatment from U-M. She received surgery, but four years later the tumor spread to her brain, and she was treated with surgery and radiation.

An expert discusses the long time usage of radiation therapy for non-cancer diseases in other countries that are now available in the United States.

With support from David and Danielle Risk, the U-M Health Patient and Family Support Services Program can provide even more hours of specialized care to people who are living with cancer.

A team of researchers from Michigan Medicine tracked how glucose is used in glioblastoma tumor cells. They showed that dietary interventions can slow brain cancer growth in mice.

Four University of Michigan faculty members have served as president of the American Society of Clinical Oncology, a rare distinction that only two other institutions can claim. ASCO is the world's leading professional organization for physicians and oncology professionals caring for people with cancer. In this episode, Nicole Fawcett, director of communications for the Rogel Cancer Center, sat down with four past ASCO Presidents and talked about the importance of the society, the impact it has had on cancer care and research as a whole and the impact here at U-M. Participants: Allen Lichter, MD, FASTRO Doug Blayney, MD Dan Hayes, MD Lori Pierce, MD

In this episode of the UMich Med Mosaic podcast, M1 host Mackenzie Kay chats with a trio of incredible M4 students, Julian Neshewat, Charlotte Jackson and Gabriela Ashenafi, just days before their medical school commencement ceremony. The conversation explores their paths and experiences at the University of Michigan Medical School with a particular focus on choosing a specialty. Gabriela talks about her journey to OBGYN, driven by her personal and family background. Julian shares the story of his late switch from a focus on Surgery to Radiology, sparked by his year off pursuing an MBA. Charlotte explains how she started out wary of Surgery, only to realize her passion for it after some reflection and experience. The group also shares advice for staying grounded and finding good mentors, while emphasizing the importance of following your own path in the world of medicine.

Michigan Medicine radiation oncology staff help grant wishes and spread joy to pediatric cancer patients at C.S. Mott Children's Hospital.

In this episode, Dr. Elizabeth Harry welcomes Keith Gran and Devin Lippert from the Office of Patient Experience (OPE). Gran is Michigan Medicine’s chief patient experience, with over 30 years in academic health care leadership. Lippert is OPE’s administrative director with over 25 years in the field. Both bring deep professional and personal insights into improving care through empathy, data and collaboration. They share how their team supports patient and caregiver well-being, highlights impactful programs like peer mentorship and medical improv, and discusses strategies to create a consistent, compassionate experience across Michigan Medicine—emphasizing that every human interaction is an opportunity to improve health care.

U-M football fans Jim and Connie Achtenberg are turning their experience with glioblastoma into hope by funding research at Rogel Cancer Center.

Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.

New treatment for metastatic castration resistant prostate cancer helped patient get back to his hobbies

Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week, according to a new study.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Radiation, used to treat half of all cancer patients, can be measured during treatment for the first time with precise 3D imaging developed at the University of Michigan.

A clinical trial in head and neck cancer explored ways to improve clinical outcomes for patients. Although the trial failed, researchers found insight into new ways to address treatment resistance.